Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
We used the RAND UCLA appropriateness method to decide appropriateness of use of osteoporosis medication after incident fracture and potential for fracture healing and make suggestions for trial design for clinical and preclinical research.



To develop appropriateness criteria to assist in the use and study of osteoporosis medications in patients with recent fracture and in the potential use of osteoporosis medications to enhance delayed fracture healing. To promote further research by suggesting preclinical and clinical trial design for studies where fracture healing is the endpoint.







RAND/UCLA appropriateness method (RUAM).



A panel of experts, both members and non-members of the International Osteoporosis Foundation Fracture Working Group, were identified consisting of geriatricians, rheumatologists, orthopedists, endocrinologists, and internists. This resulted in a round 1 panel of 15 panelists, round 2 panel of 15 members, and a round 3 panel of 14 members.



Agreement on statements and scenarios using RUAM. Three rounds of voting by panelists took place. Agreement in a third round was reached for 111 statements and scenarios, measured by median panel ratings and the amount of dispersion of panel ratings, based on the interpercentile range.



An expert panel validated a set of statements and scenarios about the use of osteoporosis medications after incident fracture and use of these medications to enhance delayed fracture healing and made recommendations for study designs to investigate the effect of osteoporosis medications on fracture healing.



The result of this exercise is intended to assist in improving patient care by identifying the appropriateness of use of osteoporosis medications after fracture and in fracture healing and to make suggestions for further preclinical and clinical research.
Cedars-Sinai Medical Center, Los Angeles, CA, USA. stuarts@bhillsra.com.|David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. stuarts@bhillsra.com.
S L
SL
Silverman
UCLA Department of Orthopedics, Santa Monica, CA, USA.
E S
ES
Kupperman
UCLA Department of Orthopedics, Santa Monica, CA, USA.
S V
SV
Bukata
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D017102:Fracture Healing; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000188:drug therapy*
D050071:Bone Density Conservation Agents
Fracture healing; Osteoporotic fracture; Trial design